1. Easily obtained from umbilical cords without invasive procedures involved |
Low survival rates after transplantation |
2. No risk of viral contamination compared to BMSC |
|
3. Limited ethical issues involved in comparison to ESCs |
|
4. Higher rates of harvest compared to cord blood MSCs |
Reduced in vivo differentiation potential |
5. Can be maintained in culture for longer periods compared to BMSCs |
|
6. May exhibit clinically low immunogenicity potential |
May fail to home at the site of injury after implantation |
7. Low tumorigenicity potential as compared to ESCs |
|
8. Primitive population and express low levels of pluripotent genes such as oct4 and sox2 |
|